<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//coyatherapeutics.com/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-announces-closing-of-26-5-million-private-placement/</loc>
		<lastmod>2024-04-22T14:56:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-scientific-advisory-board-chairman-dr-stanley-appel-to-present-updated-als-biomarker-data-at-the-2nd-annual-johnson-center-symposium/</loc>
		<lastmod>2024-04-22T14:58:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-provides-a-corporate-update-and-reports-fiscal-2023-financial-results/</loc>
		<lastmod>2024-04-22T14:59:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-presents-als-biomarker-data-at-society-of-neuroimmune-pharmacology-conference/</loc>
		<lastmod>2024-04-22T15:01:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-to-participate-in-btig-fireside-discussion/</loc>
		<lastmod>2024-04-22T15:02:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-presents-biomarker-data-on-neuroinflammatory-pathways-in-frontotemporal-dementia-ftd-at-the-ad-pd-2024-conference/</loc>
		<lastmod>2024-04-22T15:03:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-to-participate-in-the-mizuho-neuroscience-summit/</loc>
		<lastmod>2024-04-22T15:28:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-presents-updated-als-biomarker-data-at-the-2nd-annual-johnson-center-symposium/</loc>
		<lastmod>2024-04-26T16:42:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-provides-a-corporate-update-and-reports-unaudited-first-quarter-2024-financial-results/</loc>
		<lastmod>2024-05-09T20:14:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-announces-5-million-strategic-investment-by-the-alzheimers-drug-discovery-foundation-addf/</loc>
		<lastmod>2024-05-20T12:37:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-announces-the-completion-of-a-controlled-phase-2-study-of-low-dose-interleukin-2-ld-il-2-in-patients-with-alzheimers-disease/</loc>
		<lastmod>2024-05-22T15:17:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-announces-inclusion-in-the-msci-usa-micro-cap-index/</loc>
		<lastmod>2024-05-28T12:19:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-announces-acceptance-of-peer-reviewed-manuscript-in-the-medical-journal-frontiers-in-neurology/</loc>
		<lastmod>2024-06-03T14:21:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-announces-publication-of-als-study-in-peer-reviewed-journal-frontiers-in-neurology/</loc>
		<lastmod>2024-06-12T00:20:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-expands-sponsored-research-collaboration-with-houston-methodist-research-institute-along-with-funding-from-the-johnson-center-for-cellular-therapeutics-to-advance-regulatory-t-cell-e/</loc>
		<lastmod>2024-06-20T15:11:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-expands-pipeline-and-intellectual-property-portfolio-with-filing-of-new-u-s-patents-for-coya-301-in-combination-with-glucagon-like-peptide-1-glp-1-receptor-agonists/</loc>
		<lastmod>2024-07-31T13:48:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-announces-that-results-from-a-double-blind-placebo-controlled-study-in-alzheimers-disease-will-be-presented-on-october-29-2024-at-the-clinical-trials-on-alzheimers/</loc>
		<lastmod>2024-08-02T15:57:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-provides-a-corporate-update-and-reports-unaudited-second-quarter-2024-financial-results/</loc>
		<lastmod>2024-08-12T12:08:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-promotes-arun-swaminathan-ph-d-to-chief-executive-officer-effective-november-1st-2024/</loc>
		<lastmod>2024-08-19T15:23:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-to-present-at-upcoming-healthcare-conferences/</loc>
		<lastmod>2024-09-03T15:56:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-announces-subcutaneously-administered-coya-302-elicits-direct-anti-inflammatory-effect-in-brain-in-a-preclinical-inflammatory-mouse-model-of-parkinsons-disease/</loc>
		<lastmod>2024-09-16T13:25:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-to-participate-in-fireside-chat-at-the-chardan-8th-annual-genetic-medicines-conference/</loc>
		<lastmod>2024-09-24T14:44:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-chairman-and-ceo-howard-berman-selected-for-pharmavoice-100/</loc>
		<lastmod>2024-10-10T18:37:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-announces-10-0-million-private-placement/</loc>
		<lastmod>2024-10-22T17:08:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-announces-closing-of-10-0-million-private-placement/</loc>
		<lastmod>2024-10-25T02:02:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-announces-conference-call-to-report-results-from-an-investigator-initiated-phase-2-trial-of-low-dose-interleukin-2-in-patients-with-mild-to-moderate-alzheimers-disease/</loc>
		<lastmod>2024-10-28T15:15:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-announces-positive-results-of-a-double-blind-study-of-subcutaneous-low-dose-interleukin-2-ld-il-2-in-alzheimers-disease-ad-presented-at-the-clinical-trials-on-alzheimer/</loc>
		<lastmod>2024-10-29T15:23:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-announces-arun-swaminathan-ph-d-assumes-new-role-as-chief-executive-officer/</loc>
		<lastmod>2024-11-01T13:34:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-provides-a-corporate-update-and-reports-unaudited-third-quarter-2024-financial-results/</loc>
		<lastmod>2024-11-07T00:59:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-ceo-dr-arun-swaminathan-issues-letter-to-stockholders/</loc>
		<lastmod>2024-11-19T16:44:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-to-participate-in-a-fireside-chat-at-the-7th-annual-evercore-healthconx-conference/</loc>
		<lastmod>2024-11-25T15:06:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-provides-enrollment-update-of-the-investigator-initiated-phase-1-study-of-low-dose-interleukin-2-ld-il-2-ctla4-ig-fusion-protein-in-patients-with-frontotemporal-dementia-ftd/</loc>
		<lastmod>2024-12-18T14:21:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-announces-pipeline-expansion-coya-303-coya-301-in-combination-with-glp-1-receptor-agonist-for-the-treatment-of-inflammatory-diseases/</loc>
		<lastmod>2025-01-21T15:16:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference/</loc>
		<lastmod>2025-02-04T22:44:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-reports-statistically-significant-improvement-of-inflammatory-blood-markers-in-patients-with-alzheimers-disease-following-monthly-dosing-with-low-dose-il-2-further-supporti/</loc>
		<lastmod>2025-02-06T18:30:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/coya-therapeutics-to-participate-in-kol-call-hosted-by-btig-to-discuss-the-potential-treatment-of-alzheimers-disease-using-glp-1-agonists-and-combinations/</loc>
		<lastmod>2025-02-25T14:49:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://coyatherapeutics.com/news/als-drug-failures-and-why-coya-302-is-different/</loc>
		<lastmod>2025-03-08T10:44:04+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->